Latest filing published 01 Mar 2021 for Checkmate Pharmaceuticals, Inc., €4,309.
Insider track record
Kleem Chaudhary: trading record in brief
Kleem Chaudhary appears in our data through filings on Checkmate Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 22 December 2020 to 26 February 2021, the count stands at 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 1 March 2021 came the latest disclosure, an option exercise for €4,309 in Checkmate Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kleem Chaudhary
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$2.6225.1% of flowCommon StockSEC:0000899243-21-008619:0
- 2,000 shares@ US$2.6225.1% of flowCommon StockSEC:0000899243-21-002196:0
- 4,000 shares@ US$2.62100.0% of flowCommon StockSEC:0000899243-20-034984:0
3 of 3 declarations